Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers

StatusRecruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later May 25, 2027 → May 29, 2028
See other at-risk trials from City of Hope Medical Center

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from May 25, 2027 to May 29, 2028 Show 4 more changesShow less
    • Start date: Nov 29, 2022 to Jan 11, 2023
    • Eligibility criteria expanded, about 17 words
    • Secondary endpoints: details revised at 5 of 5 entries
    • Study description revised
  2. 2 versions Re-verified since Dec 18, 2024, no change to tracked fieldsv5-v6
  3. Primary and study completion dates: Aug 11, 2026 to May 25, 2027v4
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Dec 15, 2022 to Nov 29, 2022
    • Site details revised
    v3
  5. Start date: Sep 30, 2022 to Dec 15, 2022v2
  6. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
This clinical trial evaluates light therapy and occupational therapy in improving cancer related fatigue (CRF) patients with genitourinary cancers. Light therapy is a non-pharmacological and evidence-based intervention for managing fatigue in cancer patients. The use of light therapy can provide a low burden, inexpensive, and easy to disseminate intervention approach that can potentially have a larger impact on CRF. In addition, occupational therapy is a standard, but often underutilized, component of the multi-disciplinary approach to cancer care. Using the combination of light therapy and occupational therapy may be effective in CRF management.
Trial Details
NCT Number NCT05519878
Lead Sponsor City of Hope Medical Center
Collaborators: National Cancer Institute (NCI)
Conditions
(from sponsor)		 Bladder Carcinoma, Genitourinary System Neoplasm, Kidney Carcinoma, Prostate Carcinoma
Related terms Carcinoma, Renal Cell, Prostatic Neoplasms, Urinary Bladder Neoplasms
Enrollment 224 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov